Osteosarcoma is the most common type of bone cancer in dogs, and it is particularly prevalent in large breeds. Mastiffs are especially prone to this disease, and while the exact cause of ...

Vets removed nine-year-old Calvin’s scapula — his shoulder blade —along with all traces of his tumor while keeping his leg ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in ...

He’s currently working on a prospective drug therapy to target a specific protein that helps drive the progression of osteosarcoma and several other cancers in dogs and humans. His findings hold the ...

a deadly form of bone cancer. Large and giant breed dogs, such as Golden Retrievers, Boxers, Greyhounds, Labradors and German Shepherds, are at higher risk of developing this cancer. ECI® works ...

a field that compares treatment of cancers in dogs to those in people, and covers developing treatments for rare forms of cancer. OST-HER2 is an immunotherapy for osteosarcoma using a HER2 ...

ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive cell therapy, ELIAS Cancer Immunotherapy (ECI®), has received full approval from the U.S.